LifeMD, Inc. (LFMD)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$2.29-6.53%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · LFMD
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(17.1) + peer(0.2*0.0) + term(0.0) → 6.0% (capped ±15.0)
in 4 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On August 5, 2026, LifeMD, Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1.
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operations and Financial Condition. On May 6, 2026, LifeMD, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1.
Results of Operations and Financial Condition. On March 9, 2026, LifeMD, Inc. (the “Company”) issued a press release announcing its financial results for the three months and year ended December 31, 2025, and its earnings guidance for 2026. A copy of the press release is furnished herewith as Exhibit 99.1.
Results of Operations and Financial Condition. On November 17, 2025, LifeMD, Inc. issued a press release announcing its financial results for the three and nine months ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1. The information in this Item 2.02 (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing und…
Results of Operations and Financial Condition. On August 5, 2025, LifeMD, Inc. issued a press release announcing its financial results for the three and six months ended June 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1. The information in this Item 2.02 (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Se…
Results of Operations and Financial Condition. On May 6, 2025, LifeMD, Inc. issued a press release announcing its financial results for the three months ended March 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1. The information in this Item 2.02 (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities A…
Results of Operations and Financial Condition. On March 10, 2025, LifeMD, Inc. issued a press release announcing its financial results for the three months and year ended December 31, 2024, and its earnings guidance for 2025. A copy of the press release is furnished herewith as Exhibit 99.1. The information in this Item 2.02 (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporate…
shall be deemed to be furnished and not filed: Exhibit No. Exhibit 99.1 Press Release, dated January 19, 2022. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LifeMD, Inc. Dated: January 19, 2022 By: /s/ Marc Benathen Marc Benathen Chief Financial Officer
Results of Operations and Financial Condition. On May 13, 2021, LifeMD, Inc. (the “Company”) issued a press release announcing the Company’s financial and operating results for the quarter ended March 31, 2021, and that it is raising its revenue guidance for the full year 2021 from previous guidance provided by the Company. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference. The information in
Results of Operations and Financial Condition. On April 19, 2021, LifeMD, Inc. (the “Company”) issued a press release announcing that expected revenue for the first fiscal quarter of 2021 exceeds previous guidance provided by the Company. The text of the press release is furnished as Exhibit 99.1 and incorporated herein by reference.
Results of Operations and Financial Condition. On March 29, 2021, LifeMD, Inc. (the “Company”) issued a press release announcing the financial and operating results of the Company for the quarter and year ended December 31, 2020. The text of the press release is furnished as Exhibit 99.1 and incorporated herein by reference. Additionally, on March 29, 2021, the Company held an earnings phone call open to the public (the “Earnings Call”). Mr. Justin Schreiber, the Company’s Chief Executive Off…
Results of Operations and Financial Condition. On January 19, 2021, Conversion Labs, Inc. (the “Company”) issued a press release announcing preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020. A copy of the press release is included as Exhibit 99.1 to this report and is incorporated by reference into this